[144] Hims & Hers Health, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice by a holder of HIMS Class A shares reports a proposed sale and recent sales activity. The filer intends to sell 4,150 Class A shares through Fidelity Brokerage Services (NYSE) with an aggregate market value of $232,400 and an approximate sale date of 09/15/2025. The securities to be sold were acquired on 09/15/2025 by exercise of options granted on 08/10/2022, 02/24/2022 and 03/01/2023 (1,800; 2,100; and 250 shares respectively) with cash payment. The notice lists five Class A sales by Michael Y. Chi between 06/17/2025 and 08/01/2025 totaling 83,552 shares for gross proceeds of approximately $3,693,196.50. The signer represents no undisclosed material adverse information.

Positive

• Transparent disclosure of proposed sale and prior sales, including acquisition dates and option origins
• Certification that the seller does not possess undisclosed material adverse information, fulfilling Rule 144 attestation

Negative

• Significant prior dispositions by the same person: five sales from 06/17/2025 to 08/01/2025 totaling approximately $3.69 million in gross proceeds
• No 10b5-1 plan date provided, so reliance on an automatic trading plan is not documented in this notice

Insights

Securities Analyst

TL;DR: Insider exercises/options followed by multiple sales; proposed sale is modest relative to recent gross proceeds but warrants monitoring.

The filing documents option exercises and notification of a proposed sale of 4,150 Class A shares valued at $232,400. Recent reported dispositions by the same person total roughly $3.69 million in gross proceeds across five trades from June to August 2025, indicating active liquidity events rather than a single isolated transaction. This Form 144 is a routine compliance filing under Rule 144 confirming intent to sell and providing acquisition details; it does not itself disclose operational or financial performance metrics.

Corporate Governance Expert

TL;DR: The filing reflects standard insider disclosure and a certification of no undisclosed material information; governance procedures appear followed.

The filer certified the absence of undisclosed material adverse information and provided acquisition and sale details, including that the shares to be sold arise from exercised options. The notice lacks any statement of a 10b5-1 plan adoption date, so no affirmative reliance on an affirmative defense is documented here. As presented, this is a procedural disclosure consistent with transparency obligations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4150	232400.00	217641958	09/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	09/15/2025	Option Granted 08/10/2022	Issuer			1800	09/15/2025	Cash
Class A	09/15/2025	Option Granted 02/24/2022	Issuer			2100	09/15/2025	Cash
Class A	09/15/2025	Option Granted 03/01/2023	Issuer			250	09/15/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/17/2025	17102	1021844.50
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/23/2025	13750	770000.00
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/24/2025	2100	120792.00
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/31/2025	26350	1765450.00
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	08/01/2025	250	16110.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does HIMS Form 144 filed for ticker HIMS disclose?

The filing discloses a proposed sale of 4,150 Class A shares (aggregate market value $232,400) and prior sales totaling about $3,693,196.50.

Who is the seller listed in the HIMS Form 144?

Michael Y. Chi is listed as the seller for the prior transactions; the proposed sale lists Fidelity Brokerage Services as the broker.

When are the proposed sale and prior sales dated in this filing?

Proposed sale date: 09/15/2025. Prior sales dates: 06/17/2025, 07/23/2025, 07/24/2025, 07/31/2025, and 08/01/2025.

How were the securities being sold originally acquired according to the Form 144?

They were acquired by option exercises with option grant dates 08/10/2022, 02/24/2022 and 03/01/2023; payment method listed as cash.

Does the Form 144 state there is undisclosed material information?

No. The signer represents they do not know any material adverse information that has not been publicly disclosed.